Billiontoone (NASDAQ:BLLN) Stock: Insider David Tsao Sells 3,333 Shares

Billiontoone, Inc. (NASDAQ:BLLN) CTO David Tsao sold 3,333 shares of Billiontoone stock in a transaction that occurred on Thursday, September 24th. The stock was sold at an average price of $125.00, for a total value of $416,625.00. Following the completion of the sale, the chief technology officer directly owned 1,000 shares in the company, valued at approximately $125,000. The trade was a 76.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Tsao also recently made the following trade(s):

• On Wednesday, September 9th, David Tsao sold 20,000 shares of Billiontoone stock. The stock was sold at an average price of $98.77, for a total value of $1,975,400.00.
• On Tuesday, August 25th, David Tsao sold 10,000 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total value of $1,000,000.00.
• On Monday, August 10th, David Tsao sold 10,000 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total transaction of $928,600.00.

Billiontoone Price Performance

BLLN traded down $1.36 during trading hours on Monday, hitting $121.72. The company’s stock had a trading volume of 343,637 shares, compared to its average volume of 551,483. The stock has a market cap of $5.74 billion and a price-to-earnings ratio of 173.89. The business’s 50-day moving average price is $108.73 and its 200-day moving average price is $98.51. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $150.44.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The business had revenue of $109.45 million during the quarter. Sell-side analysts expect that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Billiontoone in a report on Friday, September 18th. BTIG Research decreased their price objective on Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. JPMorgan Chase & Co. decreased their price objective on Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 6th. Zacks Research cut Billiontoone from a “hold” rating to a “strong sell” rating in a report on Monday, August 31st. Finally, Canaccord Genuity Group began coverage on Billiontoone in a report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 target price for the company. Seven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Billiontoone currently has an average rating of “Hold” and an average price target of $125.88.

Institutional Trading of Billiontoone

Several institutional investors have recently added to or reduced their stakes in BLLN. Adams Street Partners LLC bought a new position in shares of Billiontoone during the fourth quarter valued at approximately $140,063,000. Wasatch Advisors LP lifted its stake in shares of Billiontoone by 40.2% during the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after acquiring an additional 148,446 shares during the last quarter. Emerald Advisers LLC lifted its stake in shares of Billiontoone by 26.8% during the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock worth $18,911,000 after acquiring an additional 50,613 shares during the last quarter. Capital International Investors purchased a new position in Billiontoone during the 4th quarter valued at $14,568,000. Finally, Emerald Mutual Fund Advisers Trust boosted its holdings in Billiontoone by 11.9% during the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock valued at $10,436,000 after acquiring an additional 14,072 shares during the period.

Billiontoone Company Profile

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.